Acuta Capital Partners, LLC Invitae Corp Transaction History

Acuta Capital Partners, LLC

  • $122 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 15, 2018
SELL
$4.69 - $10.05 $714,287 - $1.53 Million
-152,300 Closed
0 $0
Q4 2017

Feb 14, 2018
SELL
$7.86 - $9.99 $2.95 Million - $3.75 Million
-375,700 Reduced 71.16%
152,300 $1.38 Million
Q3 2017

Nov 14, 2017
BUY
$8.89 - $10.4 $4.69 Million - $5.49 Million
528,000
528,000 $4.95 Million

Others Institutions Holding NVTA

# of Institutions
56
Shares Held
7.66M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email